drugset / Trial / NCT03329638

A Study Assessing the Efficacy and Safety of DE-127 Ophthalmic Solution in Subjects With Mild or Moderate Myopia (APPLE)

NCT03329638 ↗

Phase 2 Completed 99 enrolled Santen Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate the safety and efficacy of three concentrations of DE-127 ophthalmic solution when compared to Placebo in subjects diagnosed with mild or moderate myopia. To investigate the dose response of DE-127.

Timeline

Start
2017-10-27
Primary completion
2019-09-12
Completion
2020-04-09

Drugs

EvaluationDrugModalityDoseRoute
Subject DE-127 Unknown — —

Indications